Concepedia

Richard Khan-Malek

RK

Statistics

Publications

7

Citations

201

H-Index

7

Active since

2001

Affiliations

Sanofi (United States)(Current)

Sanofi (France)

Pfizer (United States)

Health and Environmental Sciences Institute

Newcastle University

Richard Khan-Malek is an author at Sanofi (United States) specializing in medicine, renal pathophysiology, and molecular diagnostics.

Publications per year

2001–2020

7

Publications

7

Sargramostim (rhu GM-CSF) Improves Survival of Non-Human Primates with Severe Bone Marrow Suppression after Acute, High-Dose, Whole-Body Irradiation

Nicholas P. Clayton, Richard Khan-Malek, Charles A. Dangler et al. · Radiation Research · 2020 · 50 citations · Full text

, , +17

A Unified Approach for Design and Analysis of Transfer Studies for Analytical Methods

Robert Kringle, Richard Khan-Malek, Fred Snikeris et al. · Drug Information Journal · 2001 · 34 citations

, , +4

Statistical Analysis of Quantitative RT-PCR Results

Richard Khan-Malek, Ying Wang · Methods in molecular biology · 2010 · 29 citations

, , +7

Normal Ranges and Variability of Novel Urinary Renal Biomarkers in Sprague-Dawley Rats

Jean‐Charles Gautier, Thierry Gury, Magali Guffroy et al. · Toxicologic Pathology · 2014 · 28 citations

, , +10

Comparison between Male and Female Sprague-Dawley Rats in the Response of Urinary Biomarkers to Injury Induced by Gentamicin

Jean‐Charles Gautier, Thierry Gury, Magali Guffroy et al. · Toxicologic Pathology · 2014 · 27 citations · Full text

, , +14

1–5 of 7